The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort. - Damotte, Diane; Warren, Sarah; Arrondeau, Jennifer; Boudou-Rouquette, Pascaline; Mansuet-Lupo, Audrey; Biton, Jérôme; Ouakrim, Hanane; Alifano, Marco; Gervais, Claire; Bellesoeur, Audrey; Kramkimel, Nora; Tlemsani, Camille; et al. (Journal of Translational Medicine, 2019)